Harvard stem cell scientists at Brigham and Women’s Hospital have pioneered a method using steroids to make mighty stem cells, increasing their usefulness for potential cell therapies.
Unlike sports, where performance-enhancing drugs are banned, in the cell therapy field, approaches that ‘pump up’ the potency of cells to make them more effective are being used. Harvard Stem Cell Institute Principal Faculty member, Jeffrey Karp, PhD, and postdoctoral fellow James Ankrum, PhD, developed a way to significantly and uniformly enhance stem cell performance by treating cells with a commonly used class of drugs called glucocorticoid steroids. Their work appears in Scientific Reports.
“Stem cells have the potential to treat nearly every disease imaginable from heart disease and osteoporosis to arthritis and multiple sclerosis,” said Karp. “But not all stem cells are equal and often cells that are infused into patients lack the required potency to have an impact. Without highly potent cells, high doses are needed, making stem cell therapy challenging, expensive and ineffective.”
The researchers treated mesenchymal stem cells (a type of stem cell that gives rise to the bone marrow tissue) with steroids to greatly increase their expression of an important anti-inflammatory factor, making the stem cells more potent compared to non-treated cells. Observing that the cells were most potent when they were being constantly exposed to steroids, the researchers then equipped the cells with microscopic reservoirs of the drug inside them, giving them continuous access to the steroids.
“We then placed these steroid-boosted stem cells in the presence of inflamed immune cells and saw that these enhanced cells were twice as potent as unmodified cells at stopping the inflammatory process,” said Ankrum. “Our approach enables fine tuning of cell potency and control following transplantation, which could lead to more successful cell-based therapies.”
The Latest on: Stem cell performance
via Google News
The Latest on: Stem cell performance
- ABMDR Facilitates Life-Saving Stem Cell Harvesting Procedure In Yerevan Despite Pandemicon June 26, 2020 at 4:54 pm
Despite the ongoing worldwide lockdown as a result of the COVID-19 pandemic, the Armenian Bone Marrow Donor Registry performed its 35th stem cell harvesting procedure in Yerevan ...
- A healing patch holds tight to a beating hearton June 26, 2020 at 4:03 am
A 3D bioprinted ‘cardiac patch’ might be able to repair the damage caused by a heart attack. Myocardial infarction, or heart attack, is a leading killer that permanently damages heart-muscle cells ...
- Hemostemix Appeals Alberta Court's Service Ex Juris Decisionon June 24, 2020 at 5:59 pm
Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") announces that, further to its June 19, 2020 news release, Hemostemix has filed a fast track appeal in relation to the Alberta ...
- Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2020 Financial Resultson June 24, 2020 at 4:30 am
China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem ...
- BrainStorm Expands Clinical Pipeline to Evaluate NurOwn® for the Treatment of Alzheimer's Diseaseon June 24, 2020 at 4:00 am
NEW YORK, June 24, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced a new ...
- BrainStorm Cell Therapeutics to Join the Russell 2000® Index and Russell 3000® Indexon June 23, 2020 at 2:45 am
NEW YORK, June 23, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NasdaqCM: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced that its ...
- Study sheds light on why retinal ganglion cells are vulnerable to glaucomaon June 18, 2020 at 7:27 am
Millions of sufferers of glaucoma might someday benefit from a study released today in STEM CELLS in which a "disease in a dish" stem cell model was used to examine the mechanism in glaucoma that ...
- Interdisciplinary Consortium Receives Grant to Develop Next-Generation Cell-Based Cancer Vaccineson June 17, 2020 at 7:31 am
Gobain, Kanyr Pharma, and McGill partner clinical experts and engineers together to develop new cell culture technologies.
- Magnetic guidance improves stem cells' ability to treat occupational lung diseaseon June 15, 2020 at 7:26 am
Results of a study released today in STEM CELLS Translational Medicine (SCTM) may point the way to a cure for a serious lung disease called silicosis that affects millions of workers worldwide.
- Neural stem cell delivery via porous collagen scaffolds promotes neuronal differentiation and locomotion recovery in spinal cord injuryon June 15, 2020 at 2:18 am
Neural stem cell (NSC) grafts have demonstrated significant effects in animal models of spinal cord injury (SCI), yet their clinical translation remains challenging. Significant evidence suggests that ...
via Bing News